Pharmaceutical

Biocytogen and Radiance partner for bispecific antibody-drug conjugate

Biocytogen Pharmaceuticals and Radiance Biopharma have signed an exclusive option and licence agreement for a BsADC.

Jan 9, 2024 - 18:00
Biocytogen and Radiance partner for bispecific antibody-drug conjugate
Biocytogen Pharmaceuticals and Radiance Biopharma have signed an exclusive option and licence agreement for a BsADC.
Read the original article

Tags:

Previous Article

MSD acquires Harpoon for $680m to strengthen T-cell engager armoury

Next Article

BIOS Health to launch precision medicine centre in California, US

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

UnitedHealth faces class action lawsuit over algorithmic care denials in Medicare Advantage plans

UnitedHealth faces class action lawsuit over algorithmi...

Nov 15, 2023

AI is a pillar of tomorrow’s healthcare system, but limitations remain

AI is a pillar of tomorrow’s healthcare system, but lim...

Sep 29, 2023

ESMO 2023: Mirati’s Krazati and immuno-oncology combo to shape first-line NSCLC

ESMO 2023: Mirati’s Krazati and immuno-oncology combo t...

Oct 23, 2023